These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 12576464

  • 1. Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma.
    Inoue K, Chikazawa M, Fukata S, Yoshikawa C, Shuin T.
    Clin Cancer Res; 2003 Feb; 9(2):886-99. PubMed ID: 12576464
    [Abstract] [Full Text] [Related]

  • 2. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K, Chikazawa M, Fukata S, Yoshikawa C, Shuin T.
    Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
    [Abstract] [Full Text] [Related]

  • 3. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
    Inoue K, Slaton JW, Davis DW, Hicklin DJ, McConkey DJ, Karashima T, Radinsky R, Dinney CP.
    Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
    Inoue K, Slaton JW, Perrotte P, Davis DW, Bruns CJ, Hicklin DJ, McConkey DJ, Sweeney P, Radinsky R, Dinney CP.
    Clin Cancer Res; 2000 Dec; 6(12):4874-84. PubMed ID: 11156247
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
    Beecken WD, Fernandez A, Panigrahy D, Achilles EG, Kisker O, Flynn E, Joussen AM, Folkman J, Shing Y.
    Urology; 2000 Sep 01; 56(3):521-6. PubMed ID: 10962337
    [Abstract] [Full Text] [Related]

  • 6. Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.
    Inoue K, Karashima T, Fukata S, Nomura A, Kawada C, Kurabayashi A, Furihata M, Ohtsuki Y, Shuin T.
    Clin Cancer Res; 2005 Sep 15; 11(18):6669-77. PubMed ID: 16166446
    [Abstract] [Full Text] [Related]

  • 7. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
    Perrotte P, Matsumoto T, Inoue K, Kuniyasu H, Eve BY, Hicklin DJ, Radinsky R, Dinney CP.
    Clin Cancer Res; 1999 Feb 15; 5(2):257-65. PubMed ID: 10037173
    [Abstract] [Full Text] [Related]

  • 8. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
    Muramaki M, Miyake H, Hara I, Kawabata G, Kamidono S.
    J Urol; 2004 Oct 15; 172(4 Pt 1):1485-9. PubMed ID: 15371876
    [Abstract] [Full Text] [Related]

  • 9. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.
    Clin Cancer Res; 2001 Sep 15; 7(9):2840-53. PubMed ID: 11555602
    [Abstract] [Full Text] [Related]

  • 10. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 model.
    Muramaki M, Miyake H, Hara I, Kamidono S.
    Int J Oncol; 2005 Mar 15; 26(3):623-8. PubMed ID: 15703816
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr 15; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 12. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
    Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R, Dinney CP.
    Cancer Res; 2000 Apr 15; 60(8):2290-9. PubMed ID: 10786697
    [Abstract] [Full Text] [Related]

  • 13. Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy.
    Muramaki M, Miyake H, Hara I, Kamidono S.
    Clin Cancer Res; 2003 Nov 01; 9(14):5152-60. PubMed ID: 14613994
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic efficacy of the angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) for human anaplastic thyroid carcinoma in nude mice.
    Hama Y, Shimizu T, Hosaka S, Sugenoya A, Usuda N.
    Exp Toxicol Pathol; 1997 Aug 01; 49(3-4):239-47. PubMed ID: 9314059
    [Abstract] [Full Text] [Related]

  • 15. Short-term effects of TNP-470 in combination with cisplatin in the rat model of bladder cancer.
    Zhang X, Yamashita M, Uetsuki H, Kakehi Y.
    In Vivo; 2002 Aug 01; 16(5):293-7. PubMed ID: 12494866
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
    Shishido T, Yasoshima T, Denno R, Mukaiya M, Sato N, Hirata K.
    Jpn J Cancer Res; 1998 Sep 01; 89(9):963-9. PubMed ID: 9818033
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
    Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K, Fujita T.
    Cancer Res; 1993 Sep 15; 53(18):4262-7. PubMed ID: 7689930
    [Abstract] [Full Text] [Related]

  • 18. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A, Alcalde RE, Nishiyama A, Lim DD, Mese H, Akedo H, Matsumura T.
    Cancer Res; 1998 Feb 01; 58(3):462-7. PubMed ID: 9458090
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
    Kawarada Y, Ishikura H, Kishimoto T, Saito K, Takahashi T, Kato H, Yoshiki T.
    Pancreas; 1997 Oct 01; 15(3):251-7. PubMed ID: 9336788
    [Abstract] [Full Text] [Related]

  • 20. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder.
    Chikazawa M, Inoue K, Fukata S, Karashima T, Shuin T.
    Pathobiology; 2008 Oct 01; 75(6):335-45. PubMed ID: 19096229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.